Suzuki Y, Aoyagi Y, Mori S, Suda T, Naitoh A, Isokawa O, Yanagi M, Igarashi H, Asakura H
Department of Internal Medicine, Niigata University School of Medicine, Japan.
J Gastroenterol Hepatol. 1996 Apr;11(4):358-65. doi: 10.1111/j.1440-1746.1996.tb01384.x.
Heterogeneous reactivity of human serum transferrin (Tf) with lectins was analysed using patient sera to determine whether it can be used to distinguish patients with hepatocellular carcinoma (HCC) from those with liver cirrhosis (LC). Microheterogeneity of Tf was analysed by crossed immunoaffinity electrophoresis (CIAE) with concanavalin A (Con A) and Lens culinaris agglutinin (LCA). Sample sera from 58 patients with HCC, 43 patients with LC and 10 normal controls were used in this study and the results were evaluated statistically. The increments of Con A-non-reactive (C1) and -weakly reactive (C2) species of Tf were observed in HCC compared with those of LC and Norm. Significant increase in the combined percentage of Con A- C1 + C2 species was also revealed in HCC (35.5 +/- 8.5%, mean+/-s.d.) compared with those of LC (29.1 +/- 6.8%; P < 0.001) and normal controls (17.1 +/- 2.3%; P < 0.001). The elevation of LCA-reactive (L2) species of Tf was recognized in HCC (8.2 +/- 3.8%) in comparison with those of LC (4.8 +/- 3.1%; P < 0.001) and normal controls (1.3 +/- 1.7%; P < 0.001). The increment of C1 + C2 species and/or L2 species of Tf was observed in 78% (sensitivity) of patients with HCC. The specificity, the positive predictive value and the overall accuracy were 81, 88 and 72%, respectively. Positive ratio of C1 + C2 and/or L2 species was 77 and 70% in alpha-fetoprotein low and -high producing HCC patients, respectively. These results indicate that the microheterogeneity analysis of human serum Tf is useful for distinguishing patients with HCC from those with LC and normal controls.
利用患者血清分析人血清转铁蛋白(Tf)与凝集素的异质性反应,以确定其是否可用于区分肝细胞癌(HCC)患者与肝硬化(LC)患者。采用伴刀豆球蛋白A(Con A)和扁豆凝集素(LCA)通过交叉免疫亲和电泳(CIAE)分析Tf的微异质性。本研究使用了58例HCC患者、43例LC患者和10例正常对照的样本血清,并对结果进行统计学评估。与LC患者和正常对照相比,HCC患者中观察到Con A非反应性(C1)和弱反应性(C2)Tf种类增加。与LC患者(29.1±6.8%;P<0.001)和正常对照(17.1±2.3%;P<0.001)相比,HCC患者中Con A-C1 + C2种类的合并百分比也显著增加(35.5±8.5%,平均值±标准差)。与LC患者(4.8±3.1%;P<0.001)和正常对照(1.3±1.7%;P<0.001)相比,HCC患者中Tf的LCA反应性(L2)种类升高(8.2±3.8%)。78%(敏感性)的HCC患者观察到Tf的C1 + C2种类和/或L2种类增加。特异性、阳性预测值和总体准确率分别为81%、88%和72%。甲胎蛋白低产和高产HCC患者中C1 + C2和/或L2种类的阳性率分别为77%和70%。这些结果表明,人血清Tf的微异质性分析有助于区分HCC患者与LC患者和正常对照。